Extend your brand profile by curating daily news.

Sino Biological Debuts AI-Trusted and AI-Qualified Protein Collections to Accelerate AI-Driven Discovery

By Burstable Editorial Team•
Sino Biological launches two curated target protein collections to support AI-driven therapeutic and diagnostic development, addressing the critical need for well-characterized proteins in AI-designed molecule validation.
Sino Biological Debuts AI-Trusted and AI-Qualified Protein Collections to Accelerate AI-Driven Discovery

Sino Biological, Inc., a global biotechnology company specializing in recombinant proteins, antibodies, and CRO services, has introduced two dedicated target protein collections for AI-driven discovery: AI-Trusted Proteins and AI-Qualified Proteins. The collections are designed to provide researchers with well-characterized proteins that have demonstrated utility in AI research and experimental validation, as announced by NEWMEDIAWIRE.

The AI-Trusted Proteins collection comprises over 600 targets and 960 individual proteins that have been used in AI-focused company validation projects, with some featured in published research. Each protein may include characterization data such as SPR, BLI, ELISA, cell-based activity assays, SEC-HPLC, and SEC-MALS analyses. The AI-Qualified Proteins collection offers 680 targets and 1,700 individual proteins with experimentally characterized binding activity, including SPR/BLI validation data and specialized formats like biotinylated proteins. These collections are part of Sino Biological's broader portfolio of AI-Trusted Proteins and AI-Qualified Proteins.

Supporting these collections is Sino Biological's 4S System—Scale, Scope, Speed, and Supply—which ensures access to more than 11,000 recombinant target proteins, including over 1,200 biotinylated proteins, broad coverage of membrane, extracellular, and intracellular proteins, rapid production and delivery, and lot-to-lot consistency for long-term supply. Additionally, the company offers a therapeutic target directory covering 12 therapeutic areas and more than 100 diseases, enabling researchers to explore targets by disease or area.

The launch matters because AI-driven discovery relies on high-quality experimental validation to translate computational predictions into viable therapeutics. As AI accelerates recombinant protein and antibody discovery, access to well-characterized target proteins is essential for evaluating AI-designed molecules. Sino Biological's collections aim to bridge the gap between AI design and wet-lab validation, potentially speeding up the development of new drugs and diagnostics.

"AI-driven discovery depends on reliable experimental resources to evaluate designed molecules and guide subsequent research decisions," said Dr. Rob Burgess, Chief Business Officer at Sino Biological US. "By combining AI-Trusted and AI-Qualified target proteins with our 4S System, we aim to provide researchers with well-characterized target resources, broad coverage, and dependable supply to support AI-driven protein and antibody discovery."

The collections are integrated into Sino Biological's 4RISE™ AI Lab Validation Solution, which provides end-to-end wet-lab support, from high-throughput protein expression to functional validation. This integrated approach helps researchers advance AI-designed molecules from computational predictions to experimental evidence, potentially reducing timelines and improving success rates in drug development.

For more information, visit www.sinobiological.com. The original release can be viewed on www.newmediawire.com.

Burstable Editorial Team

Burstable Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.